The Mesenchymal Stem Cell Core (MSC Core) will be responsible for the production and characterization of Cynomolgus MSCs that are essential for carrying out this multi-center grant. Bone marrow aspirates will be drawn from spuma-negative donor animals and sent to the MSC Core. The aspirates will be processed and MSCs will be expanded over several passages to provide enough cells to perform the experiments. When cell-dose has been achieved, MSCs will be cryopreserved in liquid nitrogen in preparation for shipping to the research sites. A sample of the cells will be evaluated by flow cytometry to evaluate characteristics and homogeneity of the population. MSCs will also be evaluated for suppression of the mixed lymphocyte reaction since this function is critical for several experiments proposed in this application. The MSC Core will also be responsible for tracking MSCs after they are administered to recipient animal. Because these cells are going to be used to induce tolerance or mediate suppression, it will be important to correlate their appearance (or disappearance) from critical tissues with the immunological status of the recipient. We plan to use a combination of histological and molecular techniques that have proven successful at Osiris in tracking MSCs in baboons for at least 12 weeks after implantation. MSCs from male donors will be labeled with a fluorescent dye for subsequent detection in biopsy or necropsy specimens obtained from female recipients. The presence and tissue location of dye-labeled MSCs will be determined using confocal laser scanning microscopy. Estimates of MSC cell number in tissues will be deterIniI1ed using real time PCR and primers specific for the Y chromosome in male cells. Immunocytochemistry will be used to characterize host cell infiltrates surrounding transplanted cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI051728-01
Application #
6660585
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2002-09-15
Project End
2007-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Osiris Therapeutics, Inc.
Department
Type
DUNS #
City
Columbia
State
MD
Country
United States
Zip Code
21046
Addicott, Benjamin; Willman, Melissa; Rodriguez, Jose et al. (2011) Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™. Contrast Media Mol Imaging 6:7-18
Berman, Dora M; Willman, Melissa A; Han, Dongmei et al. (2010) Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes 59:2558-68
Han, Dongmei; Berman, Dora M; Willman, Melissa et al. (2010) Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients. Cell Transplant 19:1547-61
Bartholomew, Amelia; Polchert, David; Szilagyi, Erzsebet et al. (2009) Mesenchymal stem cells in the induction of transplantation tolerance. Transplantation 87:S55-7
Alegre, Maria-Luisa; Goldstein, Daniel R; Chong, Anita S (2008) Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant 13:358-65
Lee, D D; Grossman, E; Chong, A S (2008) Cellular therapies for type 1 diabetes. Horm Metab Res 40:147-54
Wang, Tongmin; Chen, Luqiu; Ahmed, Emily et al. (2008) Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol 180:5991-9
Li, Yijin; Ma, Lianli; Yin, Dengping et al. (2008) Long-term control of alloreactive B cell responses by the suppression of T cell help. J Immunol 180:6077-84
Xiang, Zhidan; Ma, Lian-Li; Manicassamy, Santhakumar et al. (2008) CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice. Transplantation 85:1205-11
Ma, Lianli; Xiang, Zhidan; Sherrill, Taylor P et al. (2008) Bioluminescence imaging visualizes activation of nuclear factor-kappaB in mouse cardiac transplantation. Transplantation 85:903-10

Showing the most recent 10 out of 11 publications